- Source: Dipentylone
N,N-Dimethylpentylone (also known as Dipentylone or simply Dimethylpentylone) is a substituted cathinone derivative with stimulant effects, which has been sold as a designer drug, first detected in Sweden in 2014.
Pharmacology
Pentylone is a known metabolite of dimethylpentylone.
Society and Culture
Dimethylpentylone was first identified in toxicology samples in the US in late 2021 and has been tracked by the Center for Forensic Science Research and Education (CFSRE) through its NPS Discovery program as an increasingly common drug mismarketed as MDMA where Eutylone was previously commonly mismarketed as MDMA.
On June 26, 2023, the United States Customs and Border Protection seized 32.2 kilograms of dimethylpentylone, sent from China labeled as "beauty products" mailed to an address in Washington, D.C.
On July 10, 2023, Jacksonville DEA Assistant Special Agent in Charge Mike Dubet gave an interview to WJXT (news4jax) reporting that dimethylpentylone has been found in possession by people attending nightclubs and bars in the Jacksonville, Florida area.
= Legal Status
=Dimethylpentylone is not specifically listed in the United States Controlled Substance Act but would be considered Schedule I as a positional isomer of the Schedule I substance N-Ethylpentylone in the United States, defined as "all isomers" within that definition.
See also
Dibutylone
Diethylpropion
Dimethylone
Ephylone
Isohexylone
MDPV
N-Ethylhexedrone
N-Ethylhexylone
Pentylone
References
Kata Kunci Pencarian:
- Dipentylone
- Pentylone
- C14H19NO3
- Substituted cathinone
- List of designer drugs
- N-Ethylpentylone
- WHO Expert Committee on Drug Dependence
- Dimethylone